Analysis of risk factors and prediction of prognosis in patients with primary liver cancer undergoing transarterial chemoembolization
Xu-Long Lu, Li-Min Yin · 2026
Read Analysis of risk factors and prediction of prognosis in patients with primary liver cancer undergoing transarterial chemoembolization by Xu-Long Lu, Li-Min Yin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13318757.txt.
Description
Xu-Long Lu and Li-Min Yin report a 2026 retrospective study of survival after chemoembolization for primary liver cancer. Outcomes after this artery-based treatment vary widely. Consecutive adults treated between January 2022 and December 2023 were followed. The team built a model to predict overall survival.
The sample held 185 patients, with a median follow-up of 30.6 months. Deaths numbered 85, and median survival reached 28.0 months in the cohort. Response rates were 48.1 percent, with disease control at 73.5 percent by their criteria. Larger tumours, vein invasion, spread outside the liver, and weaker liver function each predicted worse survival. Blood clotting and tumour marker levels mattered too. Their score discriminated well, with a C-index of 0.812 in training.
Catalog record
| CREATOR | Xu-Long Lu, Li-Min Yin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49720 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |